US Biopsy manufactures soft-tissue biopsy products, such as the TLAB Transjugular Liver Biopsy Instrument. Through the acquisition, Argon Medical becomes one of two companies competing in the transjugular biopsy market, according to the company.
“This acquisition allows us to leverage our current soft tissue biopsy portfolio and further demonstrates our commitment to growth in the interventional space,” said Argon Medical president George Leondis.
More articles on acquisitions:
Mylan to acquire U.S. rights for Aspen injection
SSM Health Care to acquire Audrain County Health Department’s home health, hospice division
Covidien acquires medical device firm Sapheon
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
